Ocimum Biosolutions is a leading integrated global genomics company providing GLP-compliant microarray services, comprehensive genomic reference databases, life science lab information management solutions and essential research consumables. Majority of the top 25 pharmaceutical companies, leading research institutes and emerging biotech companies worldwide have chosen us as their preferred outsourcing partner and utilize our expertise for understanding underlying mechanisms of diseases, discovery and prioritization of gene targets and biomarkers. There solutions span across key priority areas including BioPharmaceutical, Diagnostics, Agriculture, Food & Nutrition. Diverse research and development efforts in such key areas have benefited from our unique range of integrated services.

Gene Logic is a leading integrated genomics company providing comprehensive Genomic Reference Databases and GLP compliant Microarray Services. Over 2/3rd of the top 25 Pharma companies, leading research institutes and emerging biotech companies worldwide have chosen us as their preferred genomics partner and utilize our expertise for understanding underlying mechanisms of diseases, discovery and prioritization of gene targets & biomarkers.

MEDIZEN HUMANCARE Co., Ltd. engages in the development and provision of medical and pharmacological research, genomic analyzing, and disease forecasting services. Its services include gene information database establishment, genetic testing, medical researches, diagnosis kit development, and others. The company was founded on July 20, 2012 and is headquartered in Seoul, South Korea.

Shenzhen iCarbonX Intelligent Digital Life and Health Management Co., Ltd., established on 2018-03-28, Business scope includes general business items:Health Management Consulting(no medical);Technology development and sales of smart technology products;information Technology,Technology development of electronic products,technical consulting,Technical Services,technology transfer;E-commerce system development;general software,Industry application software,Embedded software development;Technology Development for the Internet of Things;cosmetic,sales of hygiene products;Sales of Class I medical supplies and equipment.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments),The licensing program is:none

Curigin Co., Ltd. is engaged in offering technology for specific gene and diseases. The company was founded on February 1, 2016 and is headquartered in Seoul, South Korea.

Shenzhen is a high-tech firm dedicated to the application of human micro-ecological technology to develop solutions for a healthy life. It also offers solutions for clinical research and the diagnosis and treatment of diseases.

Nanjing Jisihuiyuan Biotechnology Co., Ltd., established on 2015-04-20, Business scope includes biotechnology development,Technical Services,technology transfer,technical consulting;laboratory reagent,Sales of experimental instruments and consumables;Computer software sales and maintenance services.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

The 301 Hospital (Chinese: 三〇一医院) or People's Liberation Army General Hospital (Chinese: 中国人民解放军总医院), which constitutes simultaneously the PLA Postgraduate Medical School (Chinese: 中国人民解放军医学院), located in Beijing, China, is a military hospital directly subsidiary to Logistic Support Department of the Central Military Commission and the largest general hospital under the auspices of the People's Liberation Army. Its mission includes assuring the health of PLA and China's leaders.

We provide a marketplace where laboratories are financially incentivized to share valuable genetic biomarkers with other stakeholders. Clinicians and insurers have access to a comprehensive database of validated biomarkers, laboratories are compensated for novel contributions, and test developers mitigate regulatory risk by using a regulatory-compliant database. To achieve this, YouGene uses a patent-pending, micro-attribution royalty framework that encourages submission with income payments and trade secret protection. The result is a platform that induces laboratories, clinicians, and insurers to participate

Allscripts Software LLC, a subsidiary of Allscripts Healthcare Solutions, Inc., is a company headquartered in the United States. The firm provides software for healthcare providers.

The Group's principal activity is the provision of computer programming services and development and production of pre-packaged software. The Group deals with basic software for mainframe computers, large-scale systems and networks for government agencies as well as the financial, insurance and securities industries. The operations are carried out through the following divisions: System development and Data processing equipment. System development includes software development and system engineering services. Data processing equipment division is engaged in system development, sale and maintenance of data processing equipment.

The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).

Huawei Technologies is a telecom solutions company that offers infrastructure application software and devices with wireline, wireless, and IP technologies. The company’s products and solutions have been deployed in over 100 countries and have served 45 of the world's top 50 telecom operators as well as one third of the world's population. Huawei Technologies has 3 divisions in the United States: enterprise (IP networking and routers, wireless, storage, data center security), carrier, and consumer devices (smartphones and tablets). Founded in January 1987, Huawei Technologies is headquartered in Shenzhen, Guangdong. Its testing lab is based in Plano, Texas with an additional office in Santa Clara, California.

Ore Pharmaceuticals, Inc. operates as a drug development company, which developed drug candidates for therapeutic uses. The firm marketed its drug repositioning capabilities to pharmaceutical companies based in North America, Japan and Europe. The company was founded in September 1994 and was headquartered in Wellesley, MA.

Syntekabio is a Korean biotech firm, developing personal genome map which is expected to enable personalized medical service. The company also provides a technology for collecting and integrating decrypted whole genome data.